Gurrola Sandra M has filed 7 insider transactions across 1 company since April 2024.
Most recent transaction: a option exercise of 30 shares of Ernexa Therapeutics Inc. ($ERNA) on June 21, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 21, 2025 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | M | Common Stock | 30 | $0.00 | 110.0000 | 52,244,929 | 37.50% | 0.00% |
| June 21, 2025 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | M | Restricted Stock Units | 30 | $0.00 | 0.0000 | 52,244,929 | 0.00% | 0.00% |
| Feb. 7, 2025 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | A | Stock Option (Right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| June 21, 2024 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | M | Common Stock | 437 | $0.00 | 1,365.0000 | 0 | 47.09% | 0.00% |
| June 21, 2024 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | F | Common Stock | 180 | $1.94 | 1,185.0000 | 0 | 13.19% | 0.00% |
| June 21, 2024 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | M | Restricted Stock Units | 437 | $0.00 | 437.0000 | 0 | 50.00% | 0.00% |
| April 26, 2024 | Ernexa Therapeutics Inc. | $ERNA | Gurrola Sandra M | Sr. VP of Finance | A | Stock Option (Right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |